Raffik DE. Novel Serum FABP4 and FABP4/ Adiponectin Ratio as Predictive Biomarkers of Metabolic Risk in Type 2 Diabetes. CAJMNS [Internet]. 2025 Nov. 12 [cited 2026 Feb. 7];7(1):49-5. Available from: https://cajmns.casjournal.org/index.php/CAJMNS/article/view/3009